Local anesthetics block pain by plugging the tiny channels that nerve cells use to transmit electrical signals. These channels, called voltage-gated sodium channels, are the on-switches for nerve impulses. When an anesthetic molecule slips inside one of these channels and lodges in its inner pore, sodium ions can no longer flow through, the nerve can’t fire, and the pain signal never reaches your brain.
How Sodium Channels Carry Pain Signals
Every sensation you feel, from a pinprick to a surgical incision, travels along nerve fibers as a wave of electrical activity called an action potential. That wave depends on sodium channels embedded in the nerve cell membrane. When tissue is damaged, nearby nerve endings respond by opening their sodium channels. Positively charged sodium ions rush inward, flipping the voltage inside the cell from negative to positive. This voltage flip (depolarization) triggers the next stretch of nerve to do the same thing, and the signal races toward the spinal cord and brain.
Without functioning sodium channels, there is no voltage flip, no traveling signal, and no pain perception. That is exactly what local anesthetics exploit.
The Binding Site Inside the Channel
Local anesthetic molecules don’t just sit on the outside of a nerve. They enter the inner pore of the sodium channel and latch onto specific anchor points on the channel’s protein structure. Research published in Frontiers in Pharmacology pinpointed the key binding site: a single amino acid (a phenylalanine) deep inside the channel’s fourth domain. A neighboring amino acid (a tyrosine) provides a secondary grip. Together, these two contact points hold the drug molecule in place so it physically blocks the path sodium ions would normally travel.
This binding is “use-dependent,” meaning it gets stronger when the nerve is actively firing. Each time the channel opens, its internal shape shifts slightly, exposing the binding site more fully. So the nerves carrying the most intense, repetitive pain signals are actually the easiest for the anesthetic to shut down. Once the drug locks in, it traps part of the channel in an activated position and slows the channel’s ability to reset, keeping the nerve silent.
Which Nerve Fibers Get Blocked First
Your peripheral nerves contain a mix of fiber types bundled together. Some carry pain and temperature (small, slow fibers), some carry touch and pressure (medium fibers), and some control muscle movement (large, fast fibers). You might expect the smallest pain fibers to be blocked first, but the reality is more nuanced.
Studies on mammalian nerves show that large, fast-conducting fibers are actually blocked at the lowest drug concentrations, while small, slow-conducting C fibers (the ones responsible for dull, aching pain) require the highest concentration. This pattern held true across multiple anesthetic agents including lidocaine, bupivacaine, and tetracaine. In clinical practice, though, the order patients notice is typically pain and temperature fading first, then touch, then motor control. That’s because the drug reaches the outer layers of the nerve bundle first, and those outer fibers often serve the skin, while deeper fibers serve muscles. The interplay between fiber sensitivity and physical anatomy determines your actual experience of “going numb.”
Why the Drug Needs to Be Uncharged to Work
Local anesthetics are weak bases, meaning they exist in two forms in your tissues: a charged (ionized) form and an uncharged (non-ionized) form. Only the uncharged form can cross the fatty nerve membrane to reach the sodium channel’s inner pore. Once inside the nerve, the molecule picks up a hydrogen ion, becomes charged again, and that charged form is what actually binds to the channel.
The balance between these two forms depends on the drug’s pKa (a chemistry term for its tipping point) and the pH of the surrounding tissue. Lidocaine has a pKa of 7.8, which is close to the body’s normal pH of 7.4, so a relatively large share of its molecules are uncharged and ready to cross into the nerve. That’s why lidocaine acts fast. Bupivacaine, with a pKa of 8.1, has fewer uncharged molecules at the same tissue pH, so its onset is slower.
This chemistry also explains why local anesthetics often fail in infected tissue. Infection makes tissue more acidic, which pushes more of the drug into its charged form. Fewer molecules can cross the nerve membrane, so the block is weaker or doesn’t work at all.
What Epinephrine Adds
Many anesthetic injections include epinephrine (adrenaline) as an additive. Epinephrine constricts the blood vessels around the injection site, which slows the rate at which the anesthetic is carried away into the bloodstream. The result: more drug stays near the nerve for longer. In animal studies, adding epinephrine to lidocaine prolonged the nerve block by nearly fourfold and increased the intensity of pain relief throughout the observation period.
This vasoconstriction also reduces the peak amount of anesthetic that enters your general circulation, lowering the risk of systemic toxicity. It’s why the maximum safe dose of lidocaine jumps from 4.5 mg per kilogram of body weight (up to 300 mg total) without epinephrine to 7 mg per kilogram (up to 500 mg) with it.
Two Chemical Families of Local Anesthetics
All local anesthetics share the same basic structure: an aromatic ring on one end, an amine group on the other, and a connecting chain in the middle. The chemical bond in that connecting chain splits them into two families. Amides (like lidocaine and bupivacaine) have an amide bond and are broken down by the liver. Esters (like procaine and chloroprocaine) have an ester bond and are broken down by enzymes circulating in the blood. Esters tend to be metabolized faster, which generally means shorter duration but also a lower risk of accumulation if repeated doses are needed.
How Anesthetics Are Delivered
The method of delivery determines how large an area goes numb and how long the effect lasts.
- Topical application: A cream, gel, or spray is placed directly on the skin or mucous membrane. The anesthetic soaks through the surface layers to reach nerve endings just below. This works well for shallow procedures or to reduce the sting of a subsequent injection.
- Infiltration: The anesthetic is injected directly into the tissue around a specific area, such as the skin edges of a wound or the gum tissue next to a tooth. The drug diffuses outward from the injection point to numb local nerve endings.
- Nerve block: The injection targets a major nerve trunk upstream from the area that needs to be numb. A single injection near the right nerve can anesthetize an entire region. In dentistry, for example, an inferior alveolar nerve block numbs all the teeth on one side of the lower jaw, plus the lip and chin, from a single injection point behind the back molars.
Buffering to Speed Onset and Reduce Pain
Commercial anesthetic solutions are slightly acidic to keep them shelf-stable. That acidity is part of why injections sting. Adding a small amount of sodium bicarbonate (baking soda) right before injection raises the solution’s pH, which does two things at once: it increases the proportion of uncharged molecules so they cross nerve membranes faster, and it brings the solution closer to body pH so the injection is less painful going in.
When Too Much Enters the Bloodstream
Local anesthetics are meant to stay local. If too much drug reaches the general circulation, either from an accidental injection into a blood vessel or from exceeding safe dosage limits, it can cause a condition called local anesthetic systemic toxicity (LAST). The brain is affected first in about 80% of cases. Early warning signs include a metallic taste, ringing in the ears, tingling around the mouth, dizziness, muscle twitching, and visual disturbances. Seizures occur in up to 68% of reported cases.
Roughly one-third of cases progress to cardiovascular problems: abnormal heart rhythms, a dangerous drop in blood pressure, or in severe cases, cardiac arrest. Bupivacaine is more cardiotoxic than lidocaine, which is one reason its maximum dose is lower (2.5 mg per kilogram without epinephrine, not to exceed 175 mg per dose). The primary rescue treatment is an intravenous fat emulsion, which works by soaking up the anesthetic molecules in the blood and boosting heart function while the drug is cleared.